• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NextCure

< Previous 1 2 Next >
News headline image
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
August 06, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
July 14, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
June 04, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
June 01, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 07, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
May 04, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
April 21, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
April 07, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
March 31, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
March 05, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update
January 23, 2026
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
November 20, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
November 17, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
November 12, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results
November 05, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States
October 16, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 04, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
August 07, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
July 24, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
June 16, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
May 29, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
May 01, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
April 04, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports Full Year 2024 Financial Results
March 06, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
January 10, 2025
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Announces Acceptance of IND Application for LNCB74
December 10, 2024
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 26, 2024
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
November 19, 2024
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
November 07, 2024
From NextCure
Via GlobeNewswire
Tickers NXTC
News headline image
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
November 05, 2024
From NextCure
Via GlobeNewswire
Tickers NXTC
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap